Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247935 | SCV000315237 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000247935 | SCV000331005 | benign | not specified | 2016-08-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000298750 | SCV000375749 | benign | Methylmalonic acidemia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000351606 | SCV000483316 | benign | Mevalonic aciduria | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000389849 | SCV000483317 | benign | Hyperimmunoglobulin D with periodic fever | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000247935 | SCV000539820 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF |
ARUP Laboratories, |
RCV000605966 | SCV001159023 | benign | Methylmalonic aciduria, cblB type | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000605966 | SCV001271767 | benign | Methylmalonic aciduria, cblB type | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV000605966 | SCV001724477 | benign | Methylmalonic aciduria, cblB type | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668597 | SCV001889782 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001668597 | SCV005237659 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000605966 | SCV000733129 | benign | Methylmalonic aciduria, cblB type | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000605966 | SCV001459245 | benign | Methylmalonic aciduria, cblB type | 2020-09-16 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000247935 | SCV001918751 | benign | not specified | no assertion criteria provided | clinical testing |